V-erbA oncogene; Fragment
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m (1 revision) |
(→Function) |
||
| Line 15: | Line 15: | ||
Acts as a thyroid-hormone receptor antagonist. The v- ErbA oncogene cooperates with v-ErbB and other primarily sarcoma- inducing oncogenes in transformation of erythroblasts. It is non transforming by itself and cannot induce self-renewal of erythroblasts. Instead it blocks the residual capacity of the v- ErbB cells to differentiate terminally. | Acts as a thyroid-hormone receptor antagonist. The v- ErbA oncogene cooperates with v-ErbB and other primarily sarcoma- inducing oncogenes in transformation of erythroblasts. It is non transforming by itself and cannot induce self-renewal of erythroblasts. Instead it blocks the residual capacity of the v- ErbB cells to differentiate terminally. | ||
| - | [[ | + | [[category:Receptors]] |
| + | [[Category:HMRbase]] | ||
Current revision
Contents |
[edit] Source Organism
Avian erythroblastosis virus (strain ES4).
[edit] Taxomomy
Viruses; Retro-transcribing viruses; Retroviridae; Orthoretrovirinae;Alpharetrovirus.
[edit] Subcellular Localization
Nucleus (By similarity).
[edit] Developmental Stage
[edit] Similarity
Belongs to the nuclear hormone receptor family. NR1 subfamily. Contains 1 nuclear receptor DNA-binding domain.
[edit] Post translational Modification
[edit] Function
Acts as a thyroid-hormone receptor antagonist. The v- ErbA oncogene cooperates with v-ErbB and other primarily sarcoma- inducing oncogenes in transformation of erythroblasts. It is non transforming by itself and cannot induce self-renewal of erythroblasts. Instead it blocks the residual capacity of the v- ErbB cells to differentiate terminally.
